Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies
Yoojin Noh; Dae Ryong Kang; Dae Jung Kim; Kwang Jae Lee; Sukhyang Lee; Sooyoung Shin
Author Information: College of Pharmacy
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.